Thus, we incubated 1μg of biologically active recombinant CD66c (rCD66c), that was produced in mouse myeloma cell lines, with 7.4 × 107 PFU IAV before intranasal infection of BALB/c mice. The gene discussed is CEACAM6; the disease is plasma cell myeloma.